CN Patent

CN101626796A — 背针

Assigned to Novo Nordisk AS · Expires 2010-01-13 · 16y expired

What this patent protects

一种用于注射器的针组件，包括针套管，该针套管安装于能连接到注射器上的中心体中，并且该针组件包括背针。此外该针组件设有当启动时防止使用者物理地接触该背针的构件。

USPTO Abstract

一种用于注射器的针组件，包括针套管，该针套管安装于能连接到注射器上的中心体中，并且该针组件包括背针。此外该针组件设有当启动时防止使用者物理地接触该背针的构件。

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: CN101626796A
Jurisdiction: CN
Classification: —
Expires: 2010-01-13
Drug substance claim: No
Drug product claim: No
Assignee: Novo Nordisk AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.